We are live on ! Find out more
BGMS

Bio Green Med Solution Inc

4 hedge funds and large institutions have $3.33M invested in Bio Green Med Solution Inc in 2017 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0% more funds holding

Funds holding: 44 (0)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more ownership

Funds ownership: 0%0% (+0%)

9% less capital invested

Capital invested by funds: $3.66M → $3.33M (-$332K)

Holders
4
Holders Change
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
Increased
2
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

BGMS Hedge Fund Activity: Q1 2017 in Review

4 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution Inc (BGMS) for Q1 2017, worth a combined $3.33M — down 9.1% from $3.66M a quarter earlier.

Fund positioning in BGMS was balanced in Q1 2017: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 1 trimmed.

The largest buyer was Tang Capital Management, adding an estimated $983K. The largest seller was Renaissance Technologies, cutting an estimated $328K.

  • 4 institutional investors held Bio Green Med Solution Inc (BGMS) as of Q1 2017, unchanged from Q4 2016.
  • Funds reported $3.33M of Bio Green Med Solution Inc stock for Q1 2017, down 9.1% quarter-over-quarter.
  • 0 funds opened new Bio Green Med Solution Inc positions in Q1 2017 and 0 closed out.
  • The largest Bio Green Med Solution Inc buyer in Q1 2017 was Tang Capital Management, an estimated $983K added.
  • The largest Bio Green Med Solution Inc seller in Q1 2017 was Renaissance Technologies, an estimated $328K sold.

Based on aggregated 13F filings for Q1 2017.